News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2018 Shelley Wood October 31, 2018
News Daily News FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients Todd Neale October 12, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2018 Shelley Wood October 02, 2018
News Opinion Editor's Corner TCT 2018 TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap! Shelley Wood September 25, 2018
Presentation TCT 2018 Case 6 From Saudi Arabia: Transcaval TAVR Complicated by Double Trouble Presenter: Jorge Cortes Lawrenz, Juan F. Granada, Oscar A. Mendiz, Carlos Cabrera Arroyo, Carlos D Calderas, Anibal A. Damonte, Nabeel Ismaeil September 24, 2018
Presentation TCT 2018 Case 5 From Argentina: Transfemoral TAVR Complicated by Stuck Delivery System After Deployment Presenter: Jorge Cortes Lawrenz, Juan F. Granada, Oscar A. Mendiz, Carlos Cabrera Arroyo, Carlos D Calderas, Anibal A. Damonte, Nabeel Ismaeil September 24, 2018
Presentation TCT 2018 TCT-13: 5-Year Outcomes From the Randomized Corevalve USPivotal High Risk Trial: Final Results Presenter: Charles J. Davidson, Jeffrey J. Popma, Thomas Gleason September 21, 2018
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Daily News New Review Probes Possibility of CVD Prevention Without Aspirin Michael O'Riordan July 04, 2018
News Industry News Essential Medical Announces Positive Results from The Safe Manta Clinical Trial, The First Pivotal Trial for a Dedicated Large Bore Closure Device June 25, 2018
Presentation The Structural Heart Disease Summit 2018 Incidence, Predictors, Consequences, Prevention, and Treatment of Coronary Occlusion During TAVR: Practical Clinical Guidelines Presenter: Ariel Finkelstein June 21, 2018
Presentation The Structural Heart Disease Summit 2018 Management of Coronary Disease in AS Patients: Important Treatment Considerations (When to Consider CABG, Timing of PCI and TAVR, and Completeness of Revascularization) Presenter: Torsten P. Vahl June 21, 2018
News Conference News EuroPCR 2018 ‘Almost Perfect’ Agreement Seen Between Angiography- and CTA-Guided Treatment Decisions in Left Main, Three-Vessel Disease Yael L. Maxwell May 22, 2018
News Conference News EuroPCR 2018 EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage Shelley Wood May 17, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for April 2018 Caitlin E. Cox April 30, 2018
News Daily News Hybrid Coronary Revascularization at 5 Years: Similar Outcomes to CABG Yael L. Maxwell April 23, 2018